\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ appeared\\ well\\ and\\ did\\ not\\ have\\ abnormal\\ laboratory\\ values\\ on\\ her\\ workup\\.\ \(0\)\
\-\ no\\ treatment\\ or\\ followup\\ are\\ necessary\\,\\ as\\ long\\ as\\,\\ the\\ patient\\ remains\\ asymptomatic\\.\ \(0\)\
\-\ a\\ three\\-phase\\ ct\\ scan\\ of\\ the\\ liver\\ was\\ performed\\.\\ \\ there\\ is\\ a\\ 5\\.6\\ cm\\ focal\\ liver\\ lesion\\ is\\ present\\ within\\ the\\ right\\ lobe\\ of\\ the\\ liver\\ on\\ the\\ ct\\ scan\\.\\ \\ chunky\\ internal\\ calcifications\\ are\\ present\\.\\ \\ there\\ is\\ the\\ suggestion\\ of\\ peripheral\\ enhancement\\ and\\ fill\\ in\\ on\\ delayed\\ images\\.\\ \ \(0\)\
\-\ the\\ red\\ blood\\ cell\\ scan\\ demonstrates\\ abnormal\\ radiotracer\\ accumulation\\ within\\ the\\ anteroinferior\\ aspect\\ of\\ the\\ liver\\,\\ which\\ correlates\\ to\\ the\\ hypodense\\,\\ partially\\ clacified\\ mass\\ identififed\\ on\\ the\\ ct\\ scan\\.\ \(0\)\
\-\ cavernous\\ hemangioma\ \(14\)\
\-\ cavernous\\ hemangioma\ \(14\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ adenoma\ \(519\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ metastatic\\ lesion\ \(30\)\
\-\ fibrolamellar\\ carcinoma\ \(1\)\
\-\ 46\\-year\\-old\\ female\\ presented\\ to\\ the\\ emergency\\ room\\ with\\ right\\ lower\\ quadrant\\ pain\\.\\ \\ a\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\ was\\ performed\\ at\\ that\\ time\\ \\-\\ but\\,\\ there\\ was\\ no\\ evidence\\ for\\ appendicitis\\ on\\ the\\ scan\\.\\ \\ however\\,\\ a\\ liver\\ lesion\\ was\\ incidentally\\ found\\ and\\ the\\ patient\\ was\\ referred\\ for\\ further\\ imaging\\.\ \(0\)\
\-\ cavernous\\ malformations\\ \\(hemangiomas\\)\\ are\\ the\\ most\\ common\\ benign\\ tumor\\ affecting\\ the\\ liver\\ with\\ a\\ reported\\ incidence\\ of\\ approximately\\ 2\\%\\.\\ \\ the\\ increased\\ use\\ of\\ noninvasive\\ imaging\\ has\\ lead\\ to\\ an\\ increased\\ detection\\ of\\ asymptomatic\\ lesions\\,\\ such\\ as\\ in\\ this\\ case\\.\\ \\ hepatic\\ hemangiomas\\ can\\ occur\\ at\\ any\\ age\\,\\ but\\ are\\ more\\ common\\ in\\ older\\ patients\\,\\ with\\ female\\-to\\-male\\ ratio\\ of\\ 4\\-6\\:1\\.\\ \\ \\ female\\ patients\\ tend\\ to\\ present\\ at\\ a\\ younger\\ age\\ and\\ with\\ larger\\ tumors\\.\\ \\ there\\ is\\ no\\ association\\ with\\ oral\\ contraceptive\\ use\\,\\ as\\ with\\ hepatic\\ adenomas\\.\ \(0\)\
\-\ hemangiomas\\ are\\ composed\\ of\\ irregular\\ or\\ atypical\\ masses\\ of\\ blood\\ vessels\\.\\ \\ the\\ etiology\\ is\\ unknown\\.\\ \\ the\\ classic\\ ct\\ appearance\\ is\\ that\\ of\\ a\\ hypodense\\ lesion\\ that\\ enhances\\ gradually\\ with\\ centripedal\\ fill\\ in\\ over\\ time\\.\\ \\ the\\ differential\\ diagnosis\\ for\\ hemangiomas\\ includes\\ other\\ benign\\ or\\ malignant\\ hepatic\\ lesions\\ such\\ as\\ focal\\ nodular\\ hyperplasia\\,\\ hepatic\\ adenoma\\,\\ hepatic\\ cysts\\,\\ metastatic\\ disease\\,\\ or\\ hepatocellular\\ carcinoma\\.\\ \\ when\\ the\\ three\\-phase\\ ct\\ appearance\\ of\\ a\\ hepatic\\ lesion\\ is\\ not\\ typical\\ for\\ a\\ hemangioma\\,\\ further\\ imaging\\ with\\ a\\ nuclear\\ medicine\\ tagged\\ red\\ blood\\ cell\\ scan\\ can\\ be\\ performed\\ for\\ more\\ definitive\\ diagnosis\\.\\ \\ this\\ case\\ demonstrates\\ a\\ slightly\\ atypical\\ appearance\\ of\\ a\\ hemngioma\\ with\\ internal\\ calcifications\\.\\ \\ further\\ imaging\\ with\\ the\\ nuclear\\ medicine\\ scan\\ gives\\ a\\ more\\ definitive\\ diagnosis\\.\ \(0\)\
\-\ unless\\ the\\ lesion\\ is\\ large\\ \\(greater\\ than\\ 10\\ cm\\)\\ or\\ there\\ is\\ evidence\\ of\\ bleeding\\,\\ no\\ further\\ work\\ up\\ or\\ treatment\\ is\\ typically\\ required\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.24986595006042195\ \(0\)\
\-\ hepatic\\:\\ 0\\.2493038710044296\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.22801561309909138\ \(0\)\
\-\ scan\\:\\ 0\\.21668972816512222\ \(0\)\
\-\ liver\\:\\ 0\\.215962130030969\ \(0\)\
\-\ of\\:\\ 0\\.15316034124245634\ \(0\)\
\-\ lesion\\:\\ 0\\.1500871446778426\ \(0\)\
\-\ is\\:\\ 0\\.1428886005936191\ \(0\)\
\-\ further\\:\\ 0\\.13593344358180395\ \(0\)\
\-\ cavernous\\:\\ 0\\.13577800033164408\ \(0\)\
\-\ hemangioma\\:\\ 0\\.13166894916244332\ \(0\)\
\-\ ct\\:\\ 0\\.11918425904944355\ \(0\)\
\-\ fill\\:\\ 0\\.11674326554539774\ \(0\)\
\-\ imaging\\:\\ 0\\.10968184384591814\ \(0\)\
\-\ or\\:\\ 0\\.10890743097586292\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.10728083274218753\ \(0\)\
\-\ as\\:\\ 0\\.10480554670411764\ \(0\)\
\-\ there\\:\\ 0\\.10380412677322563\ \(0\)\
\-\ with\\:\\ 0\\.1021679030065684\ \(0\)\
\-\ hypodense\\:\\ 0\\.1013277175800673\ \(0\)\
\-\ are\\:\\ 0\\.098992843297804\ \(0\)\
\-\ nuclear\\:\\ 0\\.09872684835995296\ \(0\)\
\-\ red\\:\\ 0\\.09829126822297045\ \(0\)\
\-\ definitive\\:\\ 0\\.09531822794660168\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.09513620155446952\ \(0\)\
\-\ appearance\\:\\ 0\\.09436537756618489\ \(0\)\
\-\ focal\\:\\ 0\\.09362868225400814\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09362868225400814\ \(0\)\
\-\ performed\\:\\ 0\\.09260317574463953\ \(0\)\
\-\ medicine\\:\\ 0\\.09198292827859529\ \(0\)\
\-\ was\\:\\ 0\\.09091994987910688\ \(0\)\
\-\ blood\\:\\ 0\\.09090617436204226\ \(0\)\
\-\ more\\:\\ 0\\.08595126332809265\ \(0\)\
\-\ atypical\\:\\ 0\\.08561117925349207\ \(0\)\
\-\ clacified\\:\\ 0\\.08344141328194324\ \(0\)\
\-\ identififed\\:\\ 0\\.08344141328194324\ \(0\)\
\-\ centripedal\\:\\ 0\\.08344141328194324\ \(0\)\
\-\ hemngioma\\:\\ 0\\.08344141328194324\ \(0\)\
\-\ adenoma\\:\\ 0\\.08319534453415074\ \(0\)\
\-\ nodular\\:\\ 0\\.08310129033480987\ \(0\)\
\-\ diagnosis\\:\\ 0\\.08114361893676751\ \(0\)\
\-\ present\\:\\ 0\\.08032020763275304\ \(0\)\
\-\ use\\:\\ 0\\.07984433554660937\ \(0\)\
\-\ for\\:\\ 0\\.07907132334014716\ \(0\)\
\-\ on\\:\\ 0\\.07879083332455726\ \(0\)\
\-\ calcifications\\:\\ 0\\.0761590963806707\ \(0\)\
\-\ female\\:\\ 0\\.07553255031508559\ \(0\)\
\-\ anteroinferior\\:\\ 0\\.07198270267638571\ \(0\)\
\-\ contraceptive\\:\\ 0\\.07198270267638571\ \(0\)\
\-\ benign\\:\\ 0\\.07168332256159404\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.07104137945089153\ \(0\)\
\-\ internal\\:\\ 0\\.07032762826374274\ \(0\)\
\-\ noninvasive\\:\\ 0\\.06872028586999164\ \(0\)\
\-\ that\\:\\ 0\\.06792779525972788\ \(0\)\
\-\ no\\:\\ 0\\.0678686788708372\ \(0\)\
\-\ such\\:\\ 0\\.06712503219668219\ \(0\)\
\-\ chunky\\:\\ 0\\.06705263603598845\ \(0\)\
\-\ age\\:\\ 0\\.06551371373106085\ \(0\)\
\-\ to\\:\\ 0\\.06521998039477621\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.06442127982772566\ \(0\)\
\-\ tagged\\:\\ 0\\.06442127982772566\ \(0\)\
\-\ abnormal\\:\\ 0\\.06269375804237697\ \(0\)\
\-\ time\\:\\ 0\\.06185252930549194\ \(0\)\
\-\ adenomas\\:\\ 0\\.06071259155124925\ \(0\)\
\-\ gives\\:\\ 0\\.06071259155124925\ \(0\)\
\-\ cm\\:\\ 0\\.05993099021297901\ \(0\)\
\-\ lesions\\:\\ 0\\.05993099021297901\ \(0\)\
\-\ cell\\:\\ 0\\.05969460284155281\ \(0\)\
\-\ correlates\\:\\ 0\\.05963525948303562\ \(0\)\
\-\ evidence\\:\\ 0\\.05923079908817157\ \(0\)\
\-\ common\\:\\ 0\\.059179983773624045\ \(0\)\
\-\ at\\:\\ 0\\.059123053961930835\ \(0\)\
\-\ patients\\:\\ 0\\.05870415061198119\ \(0\)\
\-\ metastatic\\:\\ 0\\.05723228435657252\ \(0\)\
\-\ composed\\:\\ 0\\.05675329168742059\ \(0\)\
\-\ increased\\:\\ 0\\.05642902598867398\ \(0\)\
\-\ suggestion\\:\\ 0\\.05627177257935654\ \(0\)\
\-\ can\\:\\ 0\\.05476103751010163\ \(0\)\
\-\ younger\\:\\ 0\\.05456511735260982\ \(0\)\
\-\ detection\\:\\ 0\\.054372547066510055\ \(0\)\
\-\ gradually\\:\\ 0\\.054372547066510055\ \(0\)\
\-\ and\\:\\ 0\\.053908065419742794\ \(0\)\
\-\ tend\\:\\ 0\\.05329521499829643\ \(0\)\
\-\ malformations\\:\\ 0\\.05264159766681686\ \(0\)\
\-\ affecting\\:\\ 0\\.05248523914588655\ \(0\)\
\-\ demonstrates\\:\\ 0\\.05242570622765353\ \(0\)\
\-\ case\\:\\ 0\\.05242570622765353\ \(0\)\
\-\ ratio\\:\\ 0\\.05233150862403684\ \(0\)\
\-\ in\\:\\ 0\\.05191917422907867\ \(0\)\
\-\ but\\:\\ 0\\.05160261700503904\ \(0\)\
\-\ appeared\\:\\ 0\\.05159937792862054\ \(0\)\
\-\ unless\\:\\ 0\\.0513221824507846\ \(0\)\
\-\ patient\\:\\ 0\\.05091108523147021\ \(0\)\
\-\ accumulation\\:\\ 0\\.050413247202681394\ \(0\)\
\-\ treatment\\:\\ 0\\.049708770323688166\ \(0\)\
\-\ remains\\:\\ 0\\.04970015241577406\ \(0\)\
\-\ workup\\:\\ 0\\.049145634111485224\ \(0\)\
\-\ older\\:\\ 0\\.04842178476632875\ \(0\)\
\-\ values\\:\\ 0\\.04812828095155095\ \(0\)\
\-\ within\\:\\ 0\\.04806167654040026\ \(0\)\
\-\ association\\:\\ 0\\.046955170513557236\ \(0\)\
\-\ larger\\:\\ 0\\.046704558926204974\ \(0\)\
\-\ lead\\:\\ 0\\.04646063111754776\ \(0\)\
\-\ followup\\:\\ 0\\.04606800643314009\ \(0\)\
\-\ enhances\\:\\ 0\\.045991464139297646\ \(0\)\
\-\ radiotracer\\:\\ 0\\.04554519266921529\ \(0\)\
\-\ incidence\\:\\ 0\\.044914132071084016\ \(0\)\
\-\ partially\\:\\ 0\\.0447796186066067\ \(0\)\
\-\ incidentally\\:\\ 0\\.044451742974386844\ \(0\)\
\-\ appendicitis\\:\\ 0\\.04426051473960445\ \(0\)\
\-\ necessary\\:\\ 0\\.043650505360747265\ \(0\)\
\-\ room\\:\\ 0\\.04269860886642034\ \(0\)\
\-\ bleeding\\:\\ 0\\.0426455840759679\ \(0\)\
\-\ work\\:\\ 0\\.04254044785248249\ \(0\)\
\-\ etiology\\:\\ 0\\.04203216427546898\ \(0\)\
\-\ oral\\:\\ 0\\.04178823646681176\ \(0\)\
\-\ not\\:\\ 0\\.041195998628055064\ \(0\)\
\-\ delayed\\:\\ 0\\.04082934543919519\ \(0\)\
\-\ slightly\\:\\ 0\\.040700212695759304\ \(0\)\
\-\ includes\\:\\ 0\\.04057287768240213\ \(0\)\
\-\ vessels\\:\\ 0\\.04048896194943637\ \(0\)\
\-\ typical\\:\\ 0\\.04032340538019018\ \(0\)\
\-\ irregular\\:\\ 0\\.040282480252689726\ \(0\)\
\-\ unknown\\:\\ 0\\.03953779396060441\ \(0\)\
\-\ cysts\\:\\ 0\\.03953779396060441\ \(0\)\
\-\ classic\\:\\ 0\\.0390254419966731\ \(0\)\
\-\ emergency\\:\\ 0\\.03871060878846662\ \(0\)\
\-\ referred\\:\\ 0\\.03860802733117533\ \(0\)\
\-\ greater\\:\\ 0\\.038439574121867506\ \(0\)\
\-\ occur\\:\\ 0\\.038373052005113144\ \(0\)\
\-\ tumors\\:\\ 0\\.038373052005113144\ \(0\)\
\-\ laboratory\\:\\ 0\\.03788898399059896\ \(0\)\
\-\ reported\\:\\ 0\\.03757994274560199\ \(0\)\
\-\ did\\:\\ 0\\.03742925151626642\ \(0\)\
\-\ peripheral\\:\\ 0\\.03731046087600807\ \(0\)\
\-\ required\\:\\ 0\\.037251639125138965\ \(0\)\
\-\ malignant\\:\\ 0\\.0371931932346688\ \(0\)\
\-\ typically\\:\\ 0\\.03662839960549802\ \(0\)\
\-\ quadrant\\:\\ 0\\.03654660993321565\ \(0\)\
\-\ pelvis\\:\\ 0\\.03649248698987214\ \(0\)\
\-\ this\\:\\ 0\\.03585749738650626\ \(0\)\
\-\ masses\\:\\ 0\\.03552068972544577\ \(0\)\
\-\ long\\:\\ 0\\.034598321920162836\ \(0\)\
\-\ right\\:\\ 0\\.034597267089152235\ \(0\)\
\-\ differential\\:\\ 0\\.033901692935608824\ \(0\)\
\-\ found\\:\\ 0\\.03376050544621873\ \(0\)\
\-\ any\\:\\ 0\\.03372056323979001\ \(0\)\
\-\ aspect\\:\\ 0\\.03366097507635712\ \(0\)\
\-\ approximately\\:\\ 0\\.0332923392613103\ \(0\)\
\-\ her\\:\\ 0\\.03259685131475229\ \(0\)\
\-\ abdomen\\:\\ 0\\.03183629562191583\ \(0\)\
\-\ when\\:\\ 0\\.031517561256434394\ \(0\)\
\-\ however\\:\\ 0\\.03088232501306413\ \(0\)\
\-\ 10\\:\\ 0\\.030510105393123675\ \(0\)\
\-\ presented\\:\\ 0\\.03042631777757389\ \(0\)\
\-\ lobe\\:\\ 0\\.03015244250513295\ \(0\)\
\-\ enhancement\\:\\ 0\\.03003182426399621\ \(0\)\
\-\ than\\:\\ 0\\.029577314475583486\ \(0\)\
\-\ over\\:\\ 0\\.029012369127553284\ \(0\)\
\-\ tumor\\:\\ 0\\.027291281454677553\ \(0\)\
\-\ most\\:\\ 0\\.02715417555746492\ \(0\)\
\-\ other\\:\\ 0\\.02709603923418245\ \(0\)\
\-\ lower\\:\\ 0\\.02666219447846291\ \(0\)\
\-\ large\\:\\ 0\\.026142963560903835\ \(0\)\
\-\ have\\:\\ 0\\.02606497089827422\ \(0\)\
\-\ up\\:\\ 0\\.025809696169991424\ \(0\)\
\-\ well\\:\\ 0\\.025264067316932426\ \(0\)\
\-\ images\\:\\ 0\\.02413505607906631\ \(0\)\
\-\ has\\:\\ 0\\.023832656612810758\ \(0\)\
\-\ which\\:\\ 0\\.023725125608158728\ \(0\)\
\-\ disease\\:\\ 0\\.021901796736491463\ \(0\)\
\-\ be\\:\\ 0\\.02116587725921755\ \(0\)\
\-\ an\\:\\ 0\\.019952078029057657\ \(0\)\
\-\ mass\\:\\ 0\\.019929989752838898\ \(0\)\
\-\ pain\\:\\ 0\\.01867063403190416\ \(0\)\
